Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-04

FDA Approved: EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved an original ANDA for a generic fixed-dose combination tablet containing efavirenz, emtricitabine, and tenofovir disoproxil fumarate (Aurobindo Phar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFAVIRENZ (efavirenz)
  • Emtricitabine (Emtricitabine)
  • TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

ORIG AP for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)